
Nanocarriers in Prostate Cancer
Advanced Diagnosis and Treatment Strategies
- 1st Edition - May 1, 2026
- Latest edition
- Editors: Bhupendra G. Prajapati, Devesh U. Kapoor, Nemat Ali, Anand Krishnan
- Language: English
- Paperback ISBN:9 7 8 - 0 - 4 4 3 - 3 3 2 0 8 - 1
- eBook ISBN:9 7 8 - 0 - 4 4 3 - 3 3 2 0 9 - 8
Nanocarriers in Prostate Cancer: Advanced Diagnosis and Treatment Strategies provides a comprehensive, up-to-date resource on the latest advancements in nanotechnology for prosta… Read more
Purchase options

• Integrates the latest research findings with practical clinical applications
• Offers valuable insights and practical examples that help advance the understanding and application of nanotechnology in prostate cancer therapy
2. Polymeric Nanoparticles: Advancing Prostate Cancer Treatment
3. Advances in silica-based nanoparticles for targeting prostate cancer
4. Breakthrough in magnetic nanoparticles for management of prostate cancer
5. Innovative approaches of metallic (gold, silver) nanoparticles in targeting of prostate cancer
6. Recent application of liposomes, niosomes and exosomes in precise targeting of prostate cancer
7. Therapeutic Potential of Dendrimers in Prostate Cancer: Advances and Challenges
8. Carbon Nanotubes in Prostate Cancer: Emerging Frontiers in Diagnosis and Therapy
9. Targeted therapy of quantum dots against prostate cancer
10. Nanoemulsions and Nanosuspensions: Innovative Nanocarrier Systems for Prostate Cancer Management
11. Nanogels in Prostate Cancer: A Novel Avenue for Targeted Therapy and Enhanced Drug Delivery
12. DNA Origami Nanocarriers: Revolutionizing Prostate Cancer Therapy
- Edition: 1
- Latest edition
- Published: May 1, 2026
- Language: English
BP
Bhupendra G. Prajapati
DK
Devesh U. Kapoor
Dr. Devesh U. Kapoor is a Professor at Dr. Dayaram Patel Pharmacy College, Bardoli, Gujarat, where he has served since September 2010. He holds a B.Pharm from the University of Rajasthan and an M.Pharm in Pharmaceutics from Rajasthan University of Health Sciences, along with a PhD in pharmaceutical sciences. With 14 years of teaching and administrative experience, Dr. Kapoor has authored over 35 research and review articles in esteemed national and international journals and contributed to several books published by Elsevier, Bentham Science, MDPI, Springer, and Wiley. His research focuses on osmotic drug delivery systems, solid lipid nanoparticles, and microspheres. He has received significant grants for organizing national seminars and faculty development programs. Dr. Kapoor holds three design patents and has delivered over 10 expert talks at various national conferences. He is currently the editor of three international books with prominent publishers.
NA
Nemat Ali
Currently working as an Assistant Professor in the Department of Pharmacology and Toxicology at College of Pharmacy King Saud University, Riyadh Saudi Arabia. Before joining King Saud University worked as a Post-Doctoral Scholar in the School of Medicine, University of Kentucky, Lexington, USA.. Currently involved in teaching, research, and research is mainly focused on finding the molecular mechanisms involved in cancer chemoprevention and chemotherapy-induced vital organ toxicity and their prevention using natural and synthetic compounds using in-vivo and in-vitro models. He has published more than 130 research, review and book chapters in highly reputed international journals.
AK
Anand Krishnan
Dr. Anand Krishnan, Principal Investigator in Chemical Pathology, Office of the Dean, Faculty of Health Sciences, University of the Free State, South Africa. He leads the Precision Medicine Integrative Nano Diagnostics (P-MIND) laboratories, which focus on the biological functions of extracellular vesicles (EVs) in synthetic biology. His research encompasses cell surface protein modification, biomarker discovery through EVs derived from liquid biopsies, and the role of circulating biomarkers in disease development and stem cell biology. Dr. Krishnan has authored over 150 articles and edited eight books published by Elsevier, Springer, and Wiley. He received the National Research Foundation (NRF) rating for Next Generation Researchers in South Africa. In the latest list published by Stanford University, Dr. Krishnan was named among the Top 2% of the most influential scientists worldwide. He is an active member of the International Society of Extracellular Vesicles (ISEV), the African Organisation for Research and Training in Cancer (AORTIC), and the American Association of Cancer Research (AACR). Recently, he has been serving as an editor for the eLife journal, focusing on the Africa region.